| Bioactivity | CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128)[1]. |
| Name | CXCR7 antagonist-1 |
| CAS | 1613021-99-0 |
| Formula | C21H19FN6O |
| Molar Mass | 390.41 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1. |
CXCR7 antagonist-1
CAS: 1613021-99-0 F: C21H19FN6O W: 390.41
CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chem
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.